tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Cash flow

Compare
343 Followers

Monte Rosa Therapeutics Cash Flow

GLUE's free cash flow for Q3 2025 was $99.78M. For the 2025 fiscal year, GLUE's free cash flow was decreased by $100.85M and operating cash flow was $100.43M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 42.00M$ -43.80M$ -92.47M$ -59.36M$ -23.05M
Investing Cash Flow
$ -44.45M$ 88.80M$ -219.22M$ -9.65M$ -3.39M
Financing Cash Flow
$ 98.89M$ 27.49M$ 20.47M$ 377.56M$ 60.06M
End Cash Position
$ 229.12M$ 132.68M$ 60.19M$ 351.41M$ 41.70M
Free Cash Flow
$ 38.01M$ -62.84M$ -105.38M$ -69.09M$ -26.44M
Currency in USD

Monte Rosa Therapeutics Cash Flow